Type 2 Diabetes Trial, Recruiting NCT05501483 Sponsor: Karolinska Institutet Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT05501483
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are willing and able to sign a consent form agreeing to take part in the trial
  • Your body mass index (a measure of body weight relative to height) is 25 or above, meaning you are classified as overweight or obese
  • Your HbA1c blood sugar level (a measure of average blood sugar over the past few months) is at or above a certain level, suggesting raised blood sugar or prediabetes/diabetes (confirm with trial site)
  • If you are a woman who could become pregnant, you are using an effective form of birth control

Who may not be able to join:

  • Your HbA1c blood sugar level is too high, suggesting more advanced diabetes (confirm with trial site)
  • You have been diagnosed with heart disease or heart failure
  • You have a severe mental health condition
  • You have an active problem with alcohol dependency
  • You are currently using insulin to manage your blood sugar
  • You are taking blood-thinning medications (such as warfarin or similar drugs)
  • You are currently pregnant or breastfeeding
  • You have tested positive for certain antibodies linked to type 1 diabetes (GAD or IA2 antibodies)
  • Certain blood and sugar measurements suggest your body is not producing enough insulin (confirm with trial site)
  • A specific heart stress marker in your blood is above the normal range (confirm with trial site)
  • You have kidney disease
  • You have liver disease, or your liver test results are more than twice the upper normal level
  • You have a serious ongoing illness, including active cancer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +46736995215

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
8 February 2023
Est. completion
1 September 2026

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Changes in fat cell lipolysis after 6 months of treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov